We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
The CORE of Innovative and Advanced Therapies at VHIR, together with the Catalan Advanced Therapies Network of BIOCAT and within the framework of the ATMP Catalonia Series, is organizing the initiative “ATMPs: From Preclinical Discovery to First-in-Human Trials”.
This conference will focus on exploring the main scientific, regulatory, ethical, and clinical challenges in the development of Advanced Therapy Medicinal Products (ATMPs), from the preclinical phase to the first clinical trials in humans. The session will bring together a diverse range of public and private partners from both academic and industry sectors to share insights and perspectives, fostering discussion on best practices and innovative approaches in the field of advanced therapies.
14h – 14:15h Registration
14:15h – 14:50h Talk 'Welcome and Vall d’Hebron University Campus as leaders in clinical research '
14:50h – 15:10h Talk 'Kymriah and the CAR-T Revolution: Lessons from the First FDA Approval and the Road Ahead'
15:10h - 15:30h Talk 'From Bench to Trial: Regulatory Requirements for ATMP Development'
15:30h – 16:05h Round Table 'From Preclinical to First-in-Human – Ethical, Regulatory, and Trial Design Challenges in ATMP development'
16:05 – 16:20h Coffee Break
16:20h – 16:40h Talk 'Developing Academic Therapies: An Academic Development Model'
16:40h – 17:15h Round Table: 'Managing Uncertainty in ATMPs: High-Risk Administration, Uncertain Long-Term Durability, Immunogenicity, and Patient-Specific Biological Barriers'
In-person registration: Click here
Online registration: Click here
VHIR & BIOCAT – ATMP Catalonia Series: 'ATMPs: From Preclinical Discovery to First-in-Human Trials'
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.